A Comparison of the Outcomes of Distal Fingertip Amputations Treated With Either Artificial (Xeroform) or Biological Dressings

Withdrawn

• Conditions: Finger Injuries; Amputation, Traumatic

• Registration Number: NCT03968835
• Lead Sponsor: NYU Langone Health

Brief Summary

This is a prospective study looking to evaluate whether the treatment outcomes for patients who sustain a distal fingertip amputation are improved or no different when using biological dressings versus artificial dressings.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-12-24
• Study First Submitted: 2019-05-08
• Study First Submitted QC: 2019-05-28
• Study First Posted: 2019-05-30
• Status Verified: 2020-05
• Last Update Submitted: 2020-05-27
• Last Update Posted: 2020-05-29
• Primary Completion: 2021-05
• Study Completion: 2021-05

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• All individuals presenting at Bellevue Hospital for evaluation and treatment of a finger amputation distal to the germinal matrix that present along with the amputated distal fingertip unit.

Exclusion Criteria

• replantation candidate, incomplete distal finger-tip amputation

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of graft viability (for biological dressing only)	3 months
Time to complete healing up to 3 Months	3 months

Trial Locations

Locations (1)

New York University School of Medicine; 🇺🇸 New York, New York, United States